pubmed-article:20441702 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20441702 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
pubmed-article:20441702 | lifeskim:mentions | umls-concept:C0036751 | lld:lifeskim |
pubmed-article:20441702 | lifeskim:mentions | umls-concept:C0042420 | lld:lifeskim |
pubmed-article:20441702 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
pubmed-article:20441702 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:20441702 | lifeskim:mentions | umls-concept:C2348519 | lld:lifeskim |
pubmed-article:20441702 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:20441702 | pubmed:dateCreated | 2010-5-5 | lld:pubmed |
pubmed-article:20441702 | pubmed:abstractText | To investigate clinical features of childhood vasovagal syncope (VVS) and the possible relationship between changes of plasma and platelet 5-hydroxytryptamine (5-HT) and childhood VVS. | lld:pubmed |
pubmed-article:20441702 | pubmed:language | chi | lld:pubmed |
pubmed-article:20441702 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20441702 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20441702 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20441702 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20441702 | pubmed:month | Jan | lld:pubmed |
pubmed-article:20441702 | pubmed:issn | 0578-1310 | lld:pubmed |
pubmed-article:20441702 | pubmed:author | pubmed-author:LeeV SVS | lld:pubmed |
pubmed-article:20441702 | pubmed:author | pubmed-author:OrdV AVA | lld:pubmed |
pubmed-article:20441702 | pubmed:author | pubmed-author:LiJingJ | lld:pubmed |
pubmed-article:20441702 | pubmed:author | pubmed-author:WangYunY | lld:pubmed |
pubmed-article:20441702 | pubmed:author | pubmed-author:ZhengTongT | lld:pubmed |
pubmed-article:20441702 | pubmed:author | pubmed-author:PanYanY | lld:pubmed |
pubmed-article:20441702 | pubmed:author | pubmed-author:WangTian-youT... | lld:pubmed |
pubmed-article:20441702 | pubmed:author | pubmed-author:MaLi-juanLJ | lld:pubmed |
pubmed-article:20441702 | pubmed:author | pubmed-author:LiLu-pingLP | lld:pubmed |
pubmed-article:20441702 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:20441702 | pubmed:volume | 48 | lld:pubmed |
pubmed-article:20441702 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20441702 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20441702 | pubmed:pagination | 39-43 | lld:pubmed |
pubmed-article:20441702 | pubmed:meshHeading | pubmed-meshheading:20441702... | lld:pubmed |
pubmed-article:20441702 | pubmed:meshHeading | pubmed-meshheading:20441702... | lld:pubmed |
pubmed-article:20441702 | pubmed:meshHeading | pubmed-meshheading:20441702... | lld:pubmed |
pubmed-article:20441702 | pubmed:meshHeading | pubmed-meshheading:20441702... | lld:pubmed |
pubmed-article:20441702 | pubmed:meshHeading | pubmed-meshheading:20441702... | lld:pubmed |
pubmed-article:20441702 | pubmed:meshHeading | pubmed-meshheading:20441702... | lld:pubmed |
pubmed-article:20441702 | pubmed:meshHeading | pubmed-meshheading:20441702... | lld:pubmed |
pubmed-article:20441702 | pubmed:meshHeading | pubmed-meshheading:20441702... | lld:pubmed |
pubmed-article:20441702 | pubmed:meshHeading | pubmed-meshheading:20441702... | lld:pubmed |
pubmed-article:20441702 | pubmed:meshHeading | pubmed-meshheading:20441702... | lld:pubmed |
pubmed-article:20441702 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20441702 | pubmed:articleTitle | [Clinical features and changes of 5-hydroxytryptamine in children with vasovagal syncope]. | lld:pubmed |
pubmed-article:20441702 | pubmed:affiliation | Children's Hospital Affiliated to Capital Institute of Pediatrics, Beijing 100020, China. | lld:pubmed |
pubmed-article:20441702 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20441702 | pubmed:publicationType | English Abstract | lld:pubmed |
pubmed-article:20441702 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |